EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Advances in the design and delivery of RNA vaccines for infectious diseases

Abhijeet Girish Lokras, Thomas Rønnemoes Bobak, Saahil Sandeep Baghel, Federica Sebastiani, Camilla Foged

Advanced Drug Delivery Reviews · 2024

DOI: 10.1016/j.addr.2024.115419 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Advanced Drug Delivery Reviews, 2024. Verfasst von Abhijeet Girish Lokras und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, 2100 Copenhagen Ø, Denmark. Hauptthemen laut MEDLINE: COVID-19 Vaccines, COVID-19, mRNA Vaccines. Die Arbeit wurde bisher 50-mal zitiert (Crossref) und nennt 399 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Independent Research Fund Denmark, Danmarks Frie Forskningsfond, Novo Nordisk Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

RNA medicines represent a paradigm shift in treatment and prevention of critical diseases of global significance, e.g., infectious diseases. The highly successful messenger RNA (mRNA) vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) were developed at record speed during the coronavirus disease 2019 pandemic. A consequence of this is exceptionally shortened vaccine development times, which in combination with adaptability makes the RNA vaccine technology highly attractive against infectious diseases and for pandemic preparedness. Here, we review state of the art in the design and delivery of RNA vaccines for infectious diseases based on different RNA modalities, including linear mRNA, self-amplifying RNA, trans-amplifying RNA, and circular RNA. We provide an overview of the clinical pipeline of RNA vaccines for infectious diseases, and present analytical procedures, which are paramount for characterizing quality attributes and guaranteeing their quality, and we discuss future perspectives for using RNA vaccines to combat pathogens beyond SARS-CoV-2.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19 VaccinesCOVID-19mRNA VaccinesHumansSARS-CoV-2Drug Delivery SystemsAnimalsCommunicable DiseasesDrug Design

Stichwörter der Autor:innen

Delivery systemsInfectious diseasesLipid nanoparticlesNanomedicineRNAVaccinesVaccinology

Substanzen

COVID-19 VaccinesmRNA Vaccines

Autor:innen und Institutionen

  • Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, 2100 Copenhagen Ø, Denmark.
  • Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, 2100 Copenhagen Ø, Denmark; Division of Physical Chemistry, Department of Chemistry, Lund University, 22100…
  • Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, 2100 Copenhagen Ø, Denmark. Electronic address: camilla.foged@sund.ku.dk.

Förderung

  • Independent Research Fund Denmark
  • Danmarks Frie Forskningsfond
  • Novo Nordisk Foundation

Zitieren

APA

Lokras, A. G., Bobak, T. R., Baghel, S. S., Sebastiani, F., & Foged, C. (2024). Advances in the design and delivery of RNA vaccines for infectious diseases. Advanced Drug Delivery Reviews. https://doi.org/10.1016/j.addr.2024.115419

Vancouver

Lokras AG, Bobak TR, Baghel SS, Sebastiani F, Foged C. Advances in the design and delivery of RNA vaccines for infectious diseases. Advanced Drug Delivery Reviews. 2024. doi:10.1016/j.addr.2024.115419

BibTeX
@article{Lokras2024,
  author = {Lokras, Abhijeet Girish and Bobak, Thomas Rønnemoes and Baghel, Saahil Sandeep and Sebastiani, Federica and Foged, Camilla},
  title = {Advances in the design and delivery of RNA vaccines for infectious diseases},
  journal = {Advanced Drug Delivery Reviews},
  year = {2024},
  doi = {10.1016/j.addr.2024.115419}
}
Kostenlos starten →